ClinicalTrials.govpublic full text
Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction
catheter infections, end-stage renal disease, catheter, dysfunctions, blood stream infections, haemodialysis, taurolidine, tunneled, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801489
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.